164 related articles for article (PubMed ID: 27627562)
1. Interdisciplinary Aspects of Primary Hyperparathyroidism: Symptomatology in a Series of 100 Cases.
Jodkowska A; Tupikowski K; Szymczak J; Bohdanowicz-Pawlak A; Bolanowski M; Bednarek-Tupikowska G
Adv Clin Exp Med; 2016; 25(2):285-93. PubMed ID: 27627562
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of primary hyperparathyroidism from western India: a single center experience.
Gopal RA; Acharya SV; Bandgar T; Menon PS; Dalvi AN; Shah NS
J Postgrad Med; 2010; 56(2):79-84. PubMed ID: 20622385
[TBL] [Abstract][Full Text] [Related]
3. [Unsual clinical signs of primary hyperparathroidism].
Reséndiz-Colosia JA; Rodriguez-Cuevas SA; Medrano-Ortiz de Zarate ME; Flores-Díaz R; Gallegos-Hernández JF; Gómez-Acosta F
Gac Med Mex; 2009; 145(3):207-13. PubMed ID: 19685826
[TBL] [Abstract][Full Text] [Related]
4. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
[TBL] [Abstract][Full Text] [Related]
5. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
6. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic primary hyperparathyroidism.
Silverberg SJ; Walker MD; Bilezikian JP
J Clin Densitom; 2013; 16(1):14-21. PubMed ID: 23374736
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary team efforts to improve the pregnancy outcome of pregnancy complicated with primary hyperparathyroidism: case series from a single hospital.
Jiao HN; Sun LH; Liu Y; Zhou JQ; Chen X; Liu JM; Zhong HP
BMC Pregnancy Childbirth; 2021 Aug; 21(1):576. PubMed ID: 34420520
[TBL] [Abstract][Full Text] [Related]
9. Calcium/phosphate ratio: an additional tool for the clinical management of asymptomatic primary hyperparathyroidism?
Castellano E; Attanasio R; Boriano A; Gianotti L; Borretta G
J Endocrinol Invest; 2024 Jun; 47(6):1505-1511. PubMed ID: 38129742
[TBL] [Abstract][Full Text] [Related]
10. Is surgery necessary for 'mild' or 'asymptomatic' hyperparathyroidism?
Niederle B; Wémeau JL
Eur J Endocrinol; 2015 Sep; 173(3):D13-20. PubMed ID: 26101370
[TBL] [Abstract][Full Text] [Related]
11. Medical management of primary hyperparathyroidism.
Khan AA
J Clin Densitom; 2013; 16(1):60-3. PubMed ID: 23374743
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience.
Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA
Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345
[TBL] [Abstract][Full Text] [Related]
13. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center.
Zhao L; Liu JM; He XY; Zhao HY; Sun LH; Tao B; Zhang MJ; Chen X; Wang WQ; Ning G
J Clin Endocrinol Metab; 2013 Feb; 98(2):721-8. PubMed ID: 23365127
[TBL] [Abstract][Full Text] [Related]
14. Nontraditional manifestations of primary hyperparathyroidism.
Walker MD; Rubin M; Silverberg SJ
J Clin Densitom; 2013; 16(1):40-7. PubMed ID: 23374740
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study on incidence of primary hyperparathyroidism in patients with goiter].
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Pol Merkur Lekarski; 2006 Nov; 21(125):469-73. PubMed ID: 17345842
[TBL] [Abstract][Full Text] [Related]
16. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
17. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
18. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism.
Reid LJ; Muthukrishnan B; Patel D; Seckl JR; Gibb FW
J Clin Endocrinol Metab; 2019 Sep; 104(9):3692-3700. PubMed ID: 30916764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
